Brief: Kazia Launches Preclinical Collaboration With Qimr Berghofer Medical Research Institute And Announces Patent Filing
15/12/2022 12:07
Dec 15 (Reuters) - Kazia Therapeutics Ltd KZA.AX :
* KAZIA LAUNCHES PRECLINICAL COLLABORATION WITH QIMR
BERGHOFER
MEDICAL RESEARCH INSTITUTE AND ANNOUNCES PATENT FILING
Source text for Eikon: ID:nPn4B4Vnla
Further company coverage: KZA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kazia Therapeutics
See all newsBrief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million – SEC Filing
Brief: Kazia Announces Voluntary Delisting From ASX
Australia's Kazia Therapeutics slumps to 1-yr low on delisting announcement
Brief: Kazia Therapeutics Announces Intention To Voluntarily De-List From ASX
Brief: Kazia Therapeutics Seeks Trading Halt